A Bayesian compartmental model for the evaluation of 1,3-butadiene metabolism

Journal of the Royal Statistical Society. Series C: Applied Statistics

Volumn 52, Issue 3, 2003, Pages 291-305

  Mezzetti, Maura ^a   Ibrahim, Joseph G ^b   Bois, Frédéric Y ^d   Ryan, Louise M ^c   Ngo, Long ^c   Smith, Thomas J ^c  

^a BOCCONI UNIVERSITY   (Italy)

^b IL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d NONE

Author keywords

Bayesian analysis; Butadiene; Compartmental model; Hierarchical model; Pharmacokinetics

Indexed keywords

EID: 0038718014     PISSN: 00359254     EISSN: None     Source Type: Journal    
DOI: 10.1111/1467-9876.00405     Document Type: Article

References (27)

1. Andersen, M. E. (1981) A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: analysis at steady state. Toxicol. Appl. Pharmacol., 60, 509-526.
2. Bailer, A. J. and Dankovic, D. A. (1997) An introduction to the use of physiologically based pharmacokinetic models in risk assessment: review. Statist, Meth. Med. Res., 6, 341-358.
3. Bernillon, P. and Bois, F. Y. (2000) Statistical issues in toxicokinetic modeling: a Bayesian perspective. Environ. Hlth Perspect., 108, 883-893.
4. Bois, F. Y., Jackson, E. T., Pekari, K. and Smith, M. T. (1996) Population toxicokinetics of benzene. Environ. Hlth Perspect., 104, 1405-1411.
5. Bois, F. Y. and Maszle, D. R. (1997) McSim: a Monte Carlo simulation program. J. Statist. Softwr., 2.
6. Bois, F. Y., Smith, T. J., Gelman, A., Chang, H. Y. and Smith, A. E. (1999) Optimal design for a study of butadiene toxicokinetics in humans. Toxicol. Sci, 49, 213-224.
7. California Environmental Protection Agency Air Resources Board (1992) Proposed identification of 1,3-but-adiene as a toxic air contaminant. Report. Stationery Source Division, California Environmental Protection Agency Air Resources Board, Sacramento.
8. Deurenberg, P., Weststrate, J. A. and Seidell, J. C. (1991) Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br. J. Nutrn, 65, 105-114.
9. Faddy, M. J. (1993) A structured compartmental model for drug kinetics. Biometrics, 49, 243-248.
10. Filser, J. G., Johanson, G., Kessler, W., Kreuzer, P. E., Stei, P., Baur, C. and Csanady, G. A. (1993) A Pharmacokinetic Model to Describe Toxicokinetic Interactions between 1,3-butadiene and Styrene in Rats: Predictions for Human Exposure, pp. 65-78. Lyon; International Agency for Research on Cancer.
11. Fiserova-Bergerova, V. and Diaz, M. L. (1986) Determination and prediction of tissue-gas partition coefficients. Int. Arch. Occup. Environ. Hlth, 58, 75-87.
12. Gelman, A. E., Bois, F. and Jiang, J. (1996) Physiological pharmacokinetics analysis using population modeling and informative prior distributions. J. Am. Statist. Ass., 91, 1400-1412.
13. Geweke, J. (1992) Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments. In Bayesian Statistics 4 (eds J. M. Bernardo, J. O. Berger, A. P. Dawid and A. F. M. Smith), pp. 169-188. Oxford: Clarendon.
14. Harris, E. A. (1987) Measurement of dead-space volume. Clin. Sci., 73, 239-240.
15. Himmelstein, M. W., Turner, M. J., Asgharian, B. and Bond, J. A. (1996) Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Toxicology, 113, 306-309.
16. International Agency for Research on Cancer (1999) Re-evaluation of Some Organic Chemicals, Hydrazine, and Hydrogen Peroxide. Lyon: International Agency for Research on Cancer.
17. Lin, Y.-S., Smith, T. J., Kelsey, K. T. and Wypij, D. (2001) Human physiological factors affecting respiratory uptake of 1,3-butadiene. Environ. Hlth Perspect., 109, 921-926.
18. Lin, Y.-S., Smith, T. J. and Wang, P.-Y (2002) An automated exposure system for human inhalation study. Arch. Environ. Hlth, 57, 215-223.
19. Maszle, D. R. and Bois, F. Y. (1993) Program McSim - user manual. (Available from ftp://sparky.berkeley.edu/pub/mcsim.)
20. National Academy of Science (1994) Science and Judgement in Risk Assessment. Washington DC: National Academy Press.
21. Racine-Poon, A. and Smith, A. F. M. (1990) Population models. In Statistical Methodology in the Pharmaceutical Sciences (ed. D. A. S. Berry), pp. 139-162. New York: Dekker.
22. Sheiner, L. B. (1984) The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metablm Rev., 15, 153-171.
23. Smith, T. J. (1991) Pharmacokinetic models in the development of exposure indicators in epidemiology. Ann. Occup. Hyg., 35, 543-560.
24. Smith, T. J., Lin, Y.-S., Mezzetti, M., Bois, F. Y., Kelsey, K. and Ibrahim, J. (2001) Genetic and dietary factors affecting human metabolism of 1,3-butadiene. Chem. Biol Interactns, 135-136, 407-428.
25. Spear, R. C. and Bois, F. Y. (1994) Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results. Environ. Hlth Perspect., 102, 61-66.
26. Wakefield, J. C., Smith, A. F. M., Racine-Poon, A. and Gelfand, A. E. (1994) Bayesian analysis of linear and non-linear population models by using the Gibbs sampler. Appl. Statist., 43, 201-221.
27. Yuh, L., Seal, S., Davidian, M., Harrison, F., Hester, A., Kowalski, K., Vonesh, E. and Wolfinger, R. (1994) Population pharmacokinetic/pharmacodynamic methodology and applications: a bibliography. Biometrics, 50, 566-575.